AbbVie offers an annual dividend of $6.56 per share, requiring an investment of approximately $32,224 to earn $1,000 annually in dividend income.
The current stock price of AbbVie is $211.51, with a market capitalization of approximately $373.4 billion.
Diversifying with other promising dividend stocks is recommended to reduce potential risks associated with concentrating too much of one’s portfolio in a single stock.
AbbVie Inc. (NYSE:ABBV) is a well-known pharmaceutical company that focuses on developing and marketing advanced therapies. It is recognized for its strong dividend-paying history, making it an attractive option for income-focused investors. On March 17, 2025, Marjorie Taylor Greene made a purchase transaction involving shares of AbbVie.
AbbVie is highlighted as a promising dividend-paying stock. The company offers an annual dividend of $6.56 per share, distributed quarterly. To earn $1,000 annually in dividend income from AbbVie, an investor would need to purchase 152 shares. With AbbVie’s recent trading price at $212 per share, this investment would amount to approximately $32,224.
The current stock price of ABBV is $211.51, reflecting a decrease of 0.35% or $0.74. Today, the stock has traded between a low of $211.11 and a high of $213.35. Over the past year, ABBV has reached a high of $218.66 and a low of $153.58. The company, listed on the NYSE:ABBV, has a market capitalization of approximately $373.4 billion.
While investing in AbbVie might be substantial for many, diversifying with other promising dividend stocks is advisable. This strategy helps avoid concentrating too much of one’s portfolio in a single stock, reducing potential risks.
